Semaglutide improves knee replacements for patients with diabetes
For those with type 2 diabetes who have knee osteoarthritis, getting a knee replacement can be difficult because they are more likely to have surgical complications.
Novo Nordisk launches daily weight-loss pill to expand GLP-1 access
A daily pill for weight loss has officially arrived in the U.S.
Can the US Launch of NVO’s Wegovy Pill Reignite Momentum in 2026?
Shares of Novo Nordisk NVO jumped 5.2% on Monday and about 4% in the pre-market hours today as investors cheered the U.S. launch of its newly approved Wegovy pill (once-daily oral semaglutide 25 mg) to reduce excess body weight and maintain weight reduction in the long term, and to reduce the risk of major adverse cardiovascular […]
Novo Nordisk’s Wegovy® pill, the first and only oral GLP-1 for weight loss in adults, now broadly available across America – PR Newswire
Novo Nordisk’s Wegovy® pill, the first and only oral GLP-1 for weight loss in adults, now broadly available across America PR Newswire Wegovy is now available as a pill. Here’s what you need to know CNN First GLP-1 pill for obesity from Novo Nordisk launches in the U.S. CNBC Wegovy obesity pill now available at pharmacies : Shots […]
EMED PROVIDES ACCESS TO FDA-APPROVED WEGOVY® PILL THROUGH ITS TRUSTED, CLINICALLY GUIDED MODEL OF CARE
Novo Nordisk names eMed a Novocare® Recognized Care Provider for first and only oral GLP-1 for weight loss MIAMI, Jan. 6, 2026 /PRNewswire/ — eMed Population Health, the leading digital health platform for GLP-1/GIP population health management, today announced it has been named a…
Risk for Foot Disease Modestly Lower With SGLT-2 Inhibitors Versus GLP-1 Receptor Agonists in T2DM
TUESDAY, Jan. 6, 2026 — For adults with type 2 diabetes mellitus (T2DM), new users of sodium-glucose cotransporter 2 inhibitors (SGLT-2is) have a modestly lower risk for foot disease compared with glucagon-like peptide-1 receptor agonist (GLP-1…
How eggs can help you come off Wegovy – cracking the problem of weight-regain
Oksana Mizina/Shutterstock.com For millions of people, weight-loss injections such as Wegovy and Mounjaro have felt like a breakthrough that finally makes eating less feel easier. In a few short years, these so-called GLP-1 drugs have reshaped how obesity is treated and how people think about appetite and willpower. But their success raises an awkward question […]
In Structure licensing deal, Roche commits $100M to shore up GLP-1 position
In a strategic move that could protect its obesity pipeline from future patent litigation, Roche is paying $100 million to secure a license from Structure Therapeutics.
Cassidy Decries Child Vax Changes; First GLP-1 Pill for Obesity; ‘Super-Flu’ Season?
(MedPage Today) — Note that some links may require registration or subscription. Sen. Bill Cassidy, MD (R-La.), who previously cast a key vote to confirm Robert F. Kennedy Jr. as HHS Secretary, said the CDC’s reduction of the childhood immunization…
MAKE AMERICA AFFORDABLE (AND TRIM) AGAIN: Novo Nordisk launches Wegovy weight-loss pill in US, trigg
MAKE AMERICA AFFORDABLE (AND TRIM) AGAIN: Novo Nordisk launches Wegovy weight-loss pill in US, triggering price war. The Danish pharmaceutical company said on Monday that its once-a-day Wegovy pill, which received approval from the US regulator just before Christmas, was now available in the country. It launched the drug – the first and only pill […]